NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY. Mediterr J Hematol Infect Dis 2023, 15 (1), e2023019. https://doi.org/10.4084/MJHID.2023.019.